Skip to main content
Premium Trial:

Request an Annual Quote

Metabolomic Dx Raises €1.6M to Finish Development of Preeclampsia Test

NEW YORK (GenomeWeb) – Metabolomic Diagnostics today announced that it has raised €1.6 million ($2 million) in venture capital to complete development of PrePsia, a predictive diagnostic test for the early detection of preeclampsia during pregnancy. 

"Securing this new funding will allow Metabolomic Diagnostics to complete PrePsia in our laboratory and assign CE marking to bring the company to first revenues in 2017," CEO Charles Garvey said in a statement. 

The County Cork, Ireland-based company said that the money would also be used to commercialize metabolomic biomarker technology licensed from the Irish Centre for Fetal and Neonatal Translational Research.

Participants in the financing included SOSventures, Enterprise Equity, and Enterprise Ireland, as well as certain private investors. Metabolomic Diagnostics had also raised about €1.5 million in previous private financing rounds.

The Scan

Billion-Dollar Diversity Initiative

The Howard Hughes Medical Institute is now accepting applications for its new $1.5 billion initiative to boost the diversity of the scientific workforce.

Biotech Co-Founder Arrested

A co-founder of a Los Angeles-based biotech company has been arrested in connection with a murder-for-hire scheme, according to Endpoint News.

Return of the Tasmanian Tiger

The Washington Post reports that a team in Australia is working to bring the thylacine back from extinction.

Nature Papers on Genome of Individual From Pompeii, CircRNA Study Best Practices, More

In Nature this week: first sequenced genome of a person from Pompeii, best practice guidelines for circRNA studies, and more.